0000883984-13-000070.txt : 20131120 0000883984-13-000070.hdr.sgml : 20131120 20131120180052 ACCESSION NUMBER: 0000883984-13-000070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131120 FILED AS OF DATE: 20131120 DATE AS OF CHANGE: 20131120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRUMMETT BURCAR ALISON CENTRAL INDEX KEY: 0001189727 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 131233826 MAIL ADDRESS: STREET 1: C/O ICU MEDICAL INC STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-11-20 0 0000883984 ICU MEDICAL INC/DE ICUI 0001189727 BRUMMETT BURCAR ALISON 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Vice President Product Develop Common Stock 2013-11-20 4 X 0 3695.0 46.53 A 5228 D Common Stock 2013-11-20 4 X 0 5625.0 43.62 A 10853 D Common Stock 2013-11-20 4 X 0 6180.0 43.12 A 17033 D Common Stock 2013-11-20 4 S 0 15500.0 63.0545 D 1533 D Non-Qualified Stock Option (right to buy) 43.12 2013-11-20 4 X 0 6180.0 D 2021-02-02 Common Stock 6180 3125 D Non-Qualified Stock Option (right to buy) 43.62 2013-11-20 4 X 0 5625.0 D 2021-07-20 Common Stock 5625 4375 D Non-Qualified Stock Option (right to buy) 46.53 2013-11-20 4 X 0 3695.0 D 2022-02-01 Common Stock 3695 5726 D The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.90 to $63.23, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Transaction is the exercise of a derivative security; see Column 2. By: Lynn DeMartini For: Alison D. Burcar 2013-11-20